血凝酶对剖宫产术中出血的影响

目的:观察血凝酶对剖宫产术中出血的影响。方法:剖宫产手术产妇 56例,分为血凝酶组(29例)和对照组(27例),血凝酶组术前 30min用血凝酶 2单位静脉注射(静注 ),术后 2h血凝酶 2单位静注。在胎儿娩出后,立即宫体肌内注射催产素20IU,同时静脉滴注催产素 20IU。对照组只给予催产素。观察术中及术后d1出血量。结果:同对照组比较,血凝酶组手术过程中出血量明显减少(P<0. 05),术后d1出血量亦明显减少。2组比较差异有显著意义 (P<0. 05 )。结论:血凝酶可减少剖宫产的出血。

Hemostatic effect of hemocoagulase atrox in abdominal delivery

AIM: To observe the haemostatic effect of hemocoagulase atrox in abdominal delivery. METHODS: Fifty-six patients received abdominal delivery were devided into atrox group (n=29) and control group (n=27) hemocoagulase atrox 2 U was adminstrated iv drip 30 min before operation, 2 U was adminstrated iv drip 2 h after operation. Oxytocin 20 IU was injected into the body of uterus and oxytocin 20 IU was intravenous dripped after fetal disengagement. The same dosage oxytocin was given to the patients of the control group. The volumes of hemorrhage in midst of the operation and 1 d after the operation was observed. RESULTS: The volumes of hemorrhage in midst of the operation and 1 d after the operation were obviously lower than those of the control group. There was significant difference between two groups(P <0.05 ). CONCLUSION: Hemocoagulase atrox can reduce the volume of hemorrhage in abdominal delivery.